Multi-omic profiling of pediatric brain and bone cancer to discover novel prognostic biomarkers and therapeutic targets.
The purpose of my research at the Ching Lau Lab is to examine genomic and epigenomic data from pediatric cancers in order to discover molecular phenotypes, prognostic biomarkers, and candidate therapeutic targets. My work includes method and pipeline development for integration of multi-omic data in the analysis of pediatric brain and bone tumors to develop a better molecular understanding of these often-lethal cancers. Currently, my research focuses on osteosarcoma, ependymoma, and intracranial germ cell tumors.
Baylor College of Medicine
Ph.D., Quantitative and Computational Biosciences
Adv: Dr. Ching Lau
University of Michigan
B.S.E., Biomedical Engineering